ArticleRetinal cases & brief reports2025
CYTOMEGALOVIRUS RETINITIS IN NON-HIV IMMUNOCOMPROMISED INDIVIDUALS ON TOFACITINIB FOR RHEUMATOID ARTHRITIS.
Article in Retinal cases & brief reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Infectious retinitis associated with JAK inhibitors: the ongoing duality of JAK inhibitors.International journal of retina and vitreous · 2026Article
- Emerging therapeutic targets in non-infectious uveitis and scleritis.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeTo describe two patients with long-standing rheumatoid arthritis who developed cytomegalovirus (CMV) retinitis while taking tofacitinib.
methodsRetrospective case series.
resultsA 79-year-old woman with rheumatoid arthritis, treated with oral tofacitinib 11 mg once daily, presented with blurred vision and pain in the right eye. Visual acuity was hand motion, anterior segment showed iritis, and the intraocular pressure was 35 mmHg. Ophthalmoscopy revealed retinal hemorrhages and overlying vitreous hemorrhage. HIV serology showed negative results, serum CMV immunoglobulin G was positive, and aqueous polymerase chain reaction was positive for CMV (802,000 IU/mL). An 82-year-old woman with a history of rheumatoid arthritis, treated with tofacitinib 11 mg once daily, was referred for a white retinal lesion in the left eye. Visual acuity was 20/50, anterior segment was quiet, and intraocular pressure was 23 mmHg. Ophthalmoscopy revealed a yellow retinal lesion with ill-defined margins in the macula. She subsequently developed a new area of peripheral retinal whitening in the right eye. HIV serology showed negative results, serum CMV immunoglobulin G was positive, and aqueous polymerase chain reaction was positive for CMV (5,200,000 IU/mL).
conclusionDiagnosis of cytomegalovirus retinitis in non-HIV individuals requires awareness of the risk of infectious retinitis in patients taking Janus kinase inhibitors for the treatment of autoimmune disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.